Healthcare technology company HealthReveal, which equips payers and providers with data analytics and remote monitoring to ensure patients receive guideline-directed medical care, has added another $500,000 to its Series A funding with an investment from Northwell Ventures. Along with the $10.8 million HealthReveal raised a few months ago (led by GE Ventures, Greycroft Partners and Flare Capital Partners), the new funding brings the company’s total funding to date at $11.3 million.
With a majority of healthcare costs associated with complications from chronic conditions – such as amputations from diabetes or end-stage renal disease –
HealthReveal’s mission is to mitigate such risks for self-insured employers, providers and payers by helping them to identify patients whose care isn’t lining up with the best practice at the exact right time. The company applies powerful machine learning algorithms built from claims data, EHR data and, for the highest-risk patients, remote monitoring. Additionally, HealthReveal’s algorithms line up with best practice guidelines derived from specialist society recommendations and medical literature that features well-regarded, robust clinical trials.
HealthReveal was founded two years ago by Dr. Lonny Reisman, who serves as CEO of the company. Reisman previously founded ActiveHealth Management, which he later sold to Aetna (where he was CMO for nearly a decade) for $400…